Recurrent Extensive Stage Small Cell Lung Carcinoma
2 clinical trials · Condition
◉ Watch Recurrent Extensive Stage Small Cell Lung Carcinoma
| Record | Firm | Date |
|---|---|---|
| Talazoparib and Low-Dose Temozolomide in Treating Participants With Relapsed or Refractory Extensive-Stage Small Cell Lung Cancer (NCT03672773) | Jonsson Comprehensive Cancer Center | 2018-10-31 |
Track Recurrent Extensive Stage Small Cell Lung Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.